Long-term results of etiology-based thoracic endovascular aortic repair: a single-center experience

Abstract The use of thoracic endovascular aortic repair (TEVAR) for thoracic aortic aneurysm (TAA) and Stanford type B aortic dissection (TBAD) has been increasing; however, in terms of etiology, the differences of long term after TEVAR outcomes remain unexplored. Thus, we investigated etiology-specific long-term results of TEVAR for TAA and TBAD. A total of 421 TEVAR procedures were performed at our institution from July 2007 to December 2021; 249 TAA cases and 172 TBAD cases were included. Traumatic aortic dissection and aortic injury cases were excluded. The mean observation duration was 5.7 years. The overall 30-day mortality rate was 1.4% ( n = 6), with 1.2% ( n = 3) in the TAA group and 1.7% ( n = 3) in the TBAD group. The overall incidence of postoperative stroke was 0.9% ( n = 4), with 1.2% ( n = 3) and 0.6% ( n = 1) in the TAA and TBAD groups, respectively ( p = 0.90). Paraplegia developed in 1.7% ( n = 7) of patients, with 2.4% ( n = 6) in the TAA group and 0.6% ( n = 1) in the TBAD group. Freedom from aortic-related death was not significantly different between the two etiologies; however, thoracic reintervention was more common in the TBAD group ( p = 0.003), with endoleak being the most common indication for reintervention. Additionally, retrograde type A aortic dissection occurred in four TBAD cases, while migration occurred in three TAA cases. The perioperative results of TEVAR for TAA and TBAD were satisfactory. The long-term results were unfavorable owing to the occurrence of etiology-specific and common complications. In terms of the high frequency of reintervention, the long-term complications associated with TEVAR are etiology specific.